添加链接
link之家
链接快照平台
  • 输入网页链接,自动生成快照
  • 标签化管理网页链接

Specific Marker Expression and Cell State of Schwann Cells during Culture In Vitro

Zhangyin Liu, Yu-Qing Jin, [...], and Zunli Shen

Additional article information

Associated Data

Data Availability Statement

Abstract

Schwann cells (SCs) in animals exist in different developmental stages or wound repair phases, distinguished mainly by the expression of SC-specific markers. No study has yet determined SC state under in vitro culture conditions, and the specific markers expressed in SC are obscure as well. In this study, we harvested sciatic nerves from newborn mice and isolated SCs by an enzyme-digestion method, then we examined the expression profiles of ten markers (S100, p75 NTR , Sox10, Sox2, GAP43, NCAM, Krox20, Oct6, MBP, and MPZ) at both the RNA and protein levels in in vitro mouse SCs and speculated their relation with in vivo SC stages. We assayed RNA and protein levels of SC specific markers by immunofluorescence, Western Blot, and real-time quantitative RT-PCR. The results show that the expression of most markers (S100, p75 NTR , GAP43, NCAM, Krox20, Oct6, MBP and MPZ) was not detectable in all of early stage cultured SCs. The expression of transcription factors Sox10 and Sox2 was, however, detectable in all SCs. After 8 days, the positive expression rate of all markers except GAP43 and Oct6 was almost 100%.These results indicates Sox10 is a necessary marker for SC identification, while S100 is not reliable. SCs cultured in vitro express Sox2, P75 NTR , NCAM, GAP43, Oct6, and MPZ, suggesting that they are similar to in vivo undifferentiated iSCs or dedifferentiated iSCs after nerve injury.

Introduction

Schwann cells (SCs), which surround nerve fibers in the normal peripheral nerve tissue, provide structure support, conduct nervous impulses along axons, clear debris after peripheral nerve axon damage, and guide axonal regeneration [ 1 ]. Currently, three methods, including cell morphology, specific markers, and co-culture with dorsal root ganglion neurons, are usually applied to identify SCs. Among them, specific marker is the most important indicator for identifying SCs or stem cell derived Schwann cell—like cells.

Previous studies have reported several SC-specific markers, and the most commonly used are S100 [ 2 ], MBP [ 1 , 3 ], MPZ [ 4 , 5 ], P75 NTR [ 6 , 7 ], GFAP [ 6 , 8 ], NCAM [ 5 , 9 ], GAP43 [ 6 , 10 ], PMP22 [ 11 ], Sox10 [ 12 ], Oct6 [ 13 ], O4 [ 14 ], Krox20 [ 15 ] and Sox2 [ 5 ]. Among them, S100 and P75 NTR are the most frequently used markers for the identification of stem cell—derived Schwann cell—like cells [ 16 18 ]. However, because SCs are not a homogenous population, identifying in vitro cultured SC or stem cell derived Schwann cell—like cells based on a single or a few specific markers may not be a reliable method.

In animals, SC has various developmental stages or wound repair phases, and each of these has distinct specific markers [ 19 ]. SCs are originated from neural crest cells, which are further differentiated into Schwann cell precursors (SCPs) and immature Schwann cells (iSCs) during embryonic development. After the pro-myelin Schwann cell (pro-mSC) stage, two matured SCs are finally formed, which are the myelinating Schwann cell (mSC) and the non-myelinating Schwann cell (nmSC) [ 19 ]. After peripheral nerves are injured, mature SCs in the distal stump will dedifferentiate into iSCs, which will differentiate into mSCs and nmSCs after nerve regeneration [ 20 22 ].

The SC specific markers in various SC stages are different but partially overlapping. A previous study suggested that Sox10 may be the only known marker constitutively expressed in the whole SC development process [ 19 , 23 ], while S100, the widely used SC marker, is not expressed in SCPs [ 24 ]. In addition, when iSCs differentiate into mSCs, transcription factor Oct6 is first expressed in pro-mSCs, inducing the expression of downstream transcription factor Krox20, which in turn regulates the expression of myelin-associated genes MBP and MPZ [ 3 , 10 , 15 , 25 27 ]. Another study suggested that Sox2, the marker for undifferentiated stem cells, is only expressed in SCPs and iSCs [ 5 , 28 , 29 ]. In addition, P75 NTR and NCAM are both expressed in iSCs and nmSCs [ 5 , 6 , 8 ], while GAP43 is not only expressed in iSCs and nmSCs, but also in SCPs [ 1 , 6 ]. The expression pattern of common in vivo SC markers is summarized in Table 1 .

Table 1
Special markers of in vivo Schwann cells.

Given that the expression of SC markers is dynamic in vivo , we wanted to know the expression profile of in vitro cultured SCs and to understand its relation with in vivo SC stages. However, in our literature review we did not find any relevant study addressing this question.

The present study covers 10 common SC markers (S100, P75 NTR , Sox10, Sox2, GAP43, NCAM, Oct6, Krox20, MBP, and MPZ) and attempts to draw a rough marker map of SCs cultured in vitro . We observed cell morphology; generated the expression profiles of SC markers of in vitro and in vivo conditions by immunofluorescence, Western Blot and real-time quantitative RT-PCR methods; and attempted to determine the state of in vitro SC. Our data indicated that cultured SCs gradually shift from a heterogeneous state into one that is similar to in vivo iSC. In addition, we found that the commonly used markers S100 and P75 NTR were not expressed in the early stage of cultured SCs, while transcription factor Sox10 is expressed in all stages of cultured SCs, suggesting that S100 and P75 NTR may not be suitable for the identification of early SCs.

Materials and Methods

Animals

Newborn (5–7 days old) and adult (8–12 weeks old) C57BL/6 mice were purchased from Shanghai SLAC Laboratory Animal Co. Ltd. All animal protocols were approved by the Animal Experiment and Care Committee of Shanghai Jiao Tong University School of Medicine.

SC isolation purification and enrichment

Newborn mice were sacrificed by decapitation, and their sciatic nerve (SN) segments were harvested aseptically under a dissecting microscope. Nerve segments were digested by an enzymatic solution containing Collagenase NB 4 (0.26 U/ml, Serva, Germany) and Dispase II(neutral protease, grade II, 0.94 U/ml, Roche, USA), which were both dissolved into DMEM (Thermo, USA) at a concentration of 0.2%.

To digest tissues, the enzymatic solution (50 μl per segment) was added and incubated at 37°C for 80 min within a cell incubator (Thermo, USA). The mixture was then centrifuged at 600×g for 10 min. After removal of the supernatant, the cell pellet was resuspended in Schwann cell culture medium (SCCM) consisting of DMEM medium supplemented with b-FGF 0.1 mg/ml (Peprotech, USA), heregulin-β-1 0.1 mg/ml (Peprotech, USA), 2 μM forskolin (Cayman,USA), 10% fetal bovine serum (FBS) (Hyclone, Australia), Penicillin-Streptomycin (Gibco, USA) [ 30 , 31 ]. The cells were cultured in a cell incubator with a humidified atmosphere of 5% carbon dioxide at 37°C.

After 48 hours, SCs were purified and enriched as described [ 31 ]. In short, after cultured 48 hours, the culture medium was replaced with 0.2% Dispase II diluted in DMEM with a volume of 0.1 ml/m 2 . After incubation at 37°C for 20 mins, the flasks were kept shaking horizontally for 1–3 min to release detaching cells. The suspended cells were then collected into a 15-ml centrifuge tube(BD Falcon, USA) and centrifuged at 600×g for 5min. After removal of supernatant, the pellet was resuspended in SCCM and plated onto flasks at a density of 2–2.5 × 10 4 /cm 2 . This purification and enrichment was repeated every 48 hours until the Schwann cells were cultured for a total of 8 days in vitro .

Tissue Preparation

Mice were anesthetized with pentobarbitone and perfused through the left ventricle with 4% (w/v) paraformaldehyde (PFA, Sigma, USA) in phosphate-buffered saline (PBS) (pH 7.4). Unfixed tissue was used for real-time quantitative RT-PCR. The SN tissue was dissected, postfixed in 4% PFA and 10% (w/v) sucrose at 4°C for 2 hours, cryo-preserved in 30% (w/v) sucrose at 4°C overnight, embedded in O.C.T. compound, sectioned in a cryotome (10 μm). Longitudinal cryo-sections were thaw-mounted onto slides and stored at -20°C.

Immunohistochemistry

Frozen sections, after several rinses in PBS, were permeabilized and blocked with PBS containing 0.3% (v/v) Triton X-100 and 10% (v/v) goat (or rabbit) serum for 30 mins at 37°C, then incubated at 4°C overnight with primary antibodies(without primary antibodies as blank control) followed by incubation with secondary antibodies for 40 mins at 37°C. Primary antibodies were diluted in PBS containing 0.1% Triton X-100,and secondary antibodies were diluted in PBS. Cell nuclei were counterstained with 4’,6-diamidino-2-phenylindole, dihydrochloride (DAPI, Invitrogen, USA) diluted in PBS(1:500). Slides were observed under a confocal laser scanning microscope (TCS SP5, Leica, Germany).

Immunocytochemistry

Cells cultured for 2 days (at the primary passage, P0) and 8 days (at the third passage, P3) were fixed with 4% PFA in PBS at 37°C for 15 mins. Unfixed cells were used for Western blotting and real-time quantitative RT-PCR. Fixed cells, after several rinses in PBS, were permeabilized and blocked with PBS containing 0.3% Triton X-100 and 10% goat (or rabbit) serum in PBS for 30 mins at 37°C, then incubated at 4°C overnight with primary antibodies(without primary antibodies as blank control) followed by incubation with fluorophore-conjugated secondary antibodies for 30 mins at 37°C. Primary and secondary antibodies were diluted in PBS. Cell nuclei were counterstained with DAPI diluted in PBS(1:500). Cells were observed under a fluorescence microscope (Olympus, Japan).

Western blotting

For Western immunoblotting, cultured cells were homogenized in lysis buffer (0.25 M Tris-HCl, pH 6.8, 20% glycerol, 4% SDS, 10% mercaptoethanol). The protein lysates were fractionated on a SDS-PAGE gel and transferred to nitrocellulose membrane (Millipore, USA). The blotted membranes were blocked with 5% nonfat milk in Tris-buffered saline containing 0.1% Tween-20 (TBST) at room temperature for 1 hour, and the membranes were incubated overnight at 4°C with primary antibodies diluted in prepared TBST containing 3% nonfat milk. After 3 washes in TBST, the blots were reacted with horseradish peroxidase-conjugated secondary antibodies (Abmart, China) for 1 hour at room temperature and then washed again with TBST. For detection, an enhanced chemiluminescence-Western blot system (Amersham, Piscataway, USA) was used. For quantification, the X-ray films were put through a scanner (Samsung, Seoul, Korea) and analyzed with LAS image analysis system (Fujifilm, Tokyo, Japan). The picture were analysed with software ImageJ (National institutes of Health, USA) to obtain gray value of each band. Then relative gray value of each marker(gray value of special marker / gray value of β-actin)were calculated and analysed.

Primary and secondary antibodies

The following primary antibodies were used: anti-MBP (rabbit 1:250) (Abcam, UK), anti-Sox10 (rabbit 1:200) (Abcam, UK), anti-MPZ (rabbit 1:250) (Abcam, UK), anti-GAP43 (rabbit 1:250) (Abcam, UK), anti-P75 NGF Receptor (rabbit 1:500, (Abcam, UK), anti-Neural Cell Adhesion Molecule (rabbit 1:500) (Millipore, USA),anti-S100 (rabbit 1:500) (DakoCytomation, USA), Krox20 (rabbit 1:100) (Covance, USA), anti-Sox2 (rabbit 1:200) (Epitomics,USA), anti-Oct6 (goat 1:100) (Santa Cruz, USA), anti-β-actin (Abmart, China). For immunohistochemistry and immunocytochemistry tests, the secondary antibodies were conjugated with Alexa 488 and Alexa 555 (goat and rabbit 1:500) (Invitrogen, USA).

Positive rate of SC markers

After immunostaining with antibodies, SCs and fibroblasts were identified based on their morphologies. Cells with a bipolar or tripolar shape were recognized as SCs, whereas flat or polygonal cells were recognized as fibroblasts [ 32 , 33 ]. The positive rate of SCs markers was derived from the calculation of the percentage of marker-positive SCs with respect to the total number of counted SCs:

SC marker positive rate= Marker-positive SC number Total SC number × 100%

We counted at least 100 SCs from at least 3 random photo-areas at 100x magnification for each experiment. Three independent experiments were repeated and Schwann cells in each experiment were harvested from a single isolation respectively.

Real-Time quantitavtive RT-PCR

Total mRNAs using Trizol (Invitrogen, USA) were extracted from cultured cells and sciatic nerve tissue. Real-time quantitative RT-PCR was performed on the StepOnePlus instrument (Applied Biosystems, USA), using Promega M-MLV kit (Promega, USA) and SYBR green method. We set 40 cycles as a cycle cut-off point for no detection.

The primer sequences (designed by Invitrogen, USA) are listed below: -->

  • β-actin F 5'-CCTCTATGCCAACACAGT-3'

  • β-actin R 5'-AGCCACCAATCCACACAG-3'

  • S100 F 5'-GCTGAGCAAGAAAGAACTGAA-3'

  • S100 R 5'-AGCCACCAGCACAACATAC-3'

  • P75 NTR F 5'-GGTGATGGCAACCTCTACAGT 3'

  • P75 NTR R 5'-CCTCGTGGGTAAAGGAGTCTA-3'

  • Sox10 F 5'-AGATCCAGTTCCGTGTCAATAA-3'

  • Sox10 R 5'-GCGAGAAGAAGGCTAGGTG-3'

  • GAP43 F 5'-AAGGCAGGGGAAGATACCAC-3'

  • GAP43 R 5'-TTGTTCAATCTTTTGGTCCTCAT-3'

  • Krox20 F 5'-GCCCCTTTGACCAGATGAAC-3'

  • Krox20 R 5'-GGAGAATTTGCCCATGTAAGTG-3'

  • MBP F 5'-AGAGTCCGACGAGCTTCAGA-3'

  • MBP R 5'-CAGGTACTTGGATCGCTGTG-3'

  • MPZ F 5'-TCTCAGGTCACGCTCTATGTC-3'

  • MPZ R 5'-GCCAGCAGTACCGAATCAG-3'

  • NCAM F 5'-GGGAGGATGCTGTGATTGTCT-3'

  • NCAM R 5'-GCAGGTAGTTGTTGGACAGGAC-3'

  • Oct6 F 5'-CTCCTGGGGTCCTTCTAACT-3'

  • Oct6 R 5'-TTATACACAGATGCGGCTCTC-3'

  • Sox2 F 5'-GCTGGACTGCGAACTGGA-3'

  • Sox2 R 5'-GCGTTAATTTGGATGGGATTG-3' For quantification we used β-actin as a calibrator for samples (nerve tissue or cultured SCs) to which unknowns could be compared. Newborn sciatic nerve or P0 SCs were a control. We compared the unknown samples against the calibrator sample to give relative gene expression using the Comparative C T method 2 -meCT [ 34 ].

  • Statistics

    We repeated three independent experiments and Schwann cells in each experiment were harvested from a single isolation respectively. The positive rate of SC markers, results of real-time quantitative RT-PCR and gray value of Western blotting were presented in texts as mean values ±SD. For quantitative comparison and analysis, the values were subjected to Student’s t -test, significant at P < 0.05.

    Results and Discussion

    The in vivo expression profile of SC-specific markers

    To determine the expression of SC-specific markers in SN derived from newborn and adult mice, we first performed immunofluorescence assays in SN from mice of different ages. We found a significant amount of nuclei in the SN from the newborn mice, but less in the SN from the adult mice. Although expression of Sox2 was undetectable in the SN from the newborn mice ( Fig 1E ), expression of the other 9 markers could be detected ( Fig 1A 1D and and1F 1F 1J ). In the SN from the adult mice, we found no expression of Sox2 ( Fig 1e ) and only weak expression of Oct6 ( Fig 1c ), while the other 8 markers were detected with slight differences in their expression levels.

    Fig 1
    The expression of Schwann cell markers in murine sciatic nerve.

    In addition, we compared the mRNA level of SC-specific markers in SN from the newborn and adult mice by real-time quantitative RT-PCR assay and statistical analysis ( Fig 1K ). We found that the mRNA level of S100 in the adult SN was higher than that in SN from the newborn mice, while the mRNA levels of Sox10, Oct6, P75 NTR , NCAM and GAP43 in the adult SN were less than those in SN of newborn mice, suggesting a similar pattern between the mRNA level and the protein level.

    The in vitro expression profile of SC-specific markers

    After checking the in vivo expression of SC markers in SNs, we digested SNs harvested from the newborn mice by enzyme solution, and isolated cells for in vitro culture. We observed two kinds of distinct cell morphology under light microscopy: some cells had a bipolar or tripolar spindle shape with a small cytoplasm / nuclear ratio and a strong refraction rate (Fig (Fig2a 2a and and2c, 2c , arrow, arrowhead), which are consistent with the morphology of SCs [ 35 ]. In contrast, other cells were flat and irregularly shaped with a large cytoplasm / nuclear ratio and a poor refraction rate (Fig (Fig2a 2a and and2c 2c asterisk), which were recognized as fibroblasts [ 35 ]. After three rounds of purification and culture, the obtained SCs had very little contamination from fibroblasts ( Fig 2E ).

    Fig 2
    The expression of S100 and P75 NTR in in vitro cultured SCs.

    The in vitro expression of S100 and P75 NTR , classic SC markers

    We first checked the expression levels of S100 and P75 NTR , the most widely used SC markers in the field of neuron development and regeneration, in in vitro cultured SCs. Immunofluorescence staining data showed that in the early stage of SC culture SCs didn’t totally express S100 and P75 NTR ( Fig 2a 2d arrow), and some SCs could not express either marker ( Fig 2a 2d , arrowhead), which show a staining pattern similar to fibroblasts ( Fig 2a 2d , asterisks). After three passage culture, all SCs expressed S100 and P75 NTR ( Fig 2E 2H ). In P0 SCs, the early stage of cultured cells, the positive rates for S100 and P75 NTR were 85.84% ± 1.86% and 93.57% ± 3.40%, respectively. Interestingly, the positive rates for both markers reached 100% in P3 cultured SC ( Fig 2I ). After extracting total proteins from SCs at different time points and assaying by Western blot, we found that the protein levels of S100 in P3 SCs were higher than those in P0 SCs ( Fig 2J ). The grey value of S100 in P0 SCs and P3 SCs were 0.540 ± 0.014 and 0.596 ± 0.012. While the protein levels of P75 NTR in P3 SCs were significantly higher than those in P0 SCs, which grey value in P0 SCs and P3 SCs were 0.435 ± 0.020 and 0.738 ± 0.023, respectively. Real-time quantitative RT-PCR data showed that the mRNA level of S100 in P0 SCs was significantly higher than that in P3 SCs, while the opposite trend was detected in the mRNA level of P75 NTR ( Fig 2K ).

    The expression profile of transcription factors Sox10, Sox2, Oct6 and Krox20

    We also detected the expression of Sox10, Sox2, Oct6 and Krox20, four transcription factors involved in regulating the development, differentiation, and myelination of SCs [ 1 , 19 , 36 , 37 ]. We found that Sox10 and Sox2 are constitutively expressed in all SCs with 100% expression rate ( Fig 3a 3d arrow, Fig 3I ), but not in fibroblasts ( Fig 3a 3d asterisk). The protein levels of Sox10 and Sox2 were higher in P3 SCs than those in P0 SCs ( Fig 3J ). The grey value of Sox10 in P0 SCs and P3 SCs were 0.738 ± 0.013 and 0.863 ± 0.011, and the grey value of Sox2 were 0.098 ± 0.012 and 0.341 ± 0.013.

    Fig 3
    The expression of Sox10 and Sox2 in cultured SCs.

    The mRNA level of Sox10 in P3 SCs was higher than that in P0 SCs, while no significant difference in the mRNA level of Sox2 was detected at different culture times ( Fig 3K ). Surprisingly, the transcription factor Oct6 were not expressed in all P0 and P3 SCs ( Fig 4 ), and the positive rate was 82.59% ± 4.13% and 92.64% ± 3.49%, respectively ( Fig 4K ). To further verify this result, we did Sox10 and Oct6 double staining in P3 SCs (Fig (Fig4E, 4E , ,4F, 4F , ,4a 4a 4d ) and found that most SCs were Sox10 + / Oct6 + , while the rest part of SCs were Sox10 + / Oct6 - . In contrast, fibroblasts were all Sox10 - / Oct6 - (Fig (Fig4E 4E and and4F 4F ).

    Fig 4
    The expression of Oct6 and Krox20 in in vitro cultured SCs.

    Furthermore, the expression of Krox20, the downstream transcription factor of Oct6, was similar to that of S100. It is not expressed in all in early in vitro cultured SCs (Fig (Fig4e 4e and and4f 4f arrowhead), and the positive expression rate is approximately 91.67% ± 1.71% ( Fig 4K ). After cultured for 8 days, Krox20 is expressed in all SCs. The protein levels of Oct6 and Krox20 in P3 SCs was higher than those in P0 SCs ( Fig 4L ), and the grey value of Oct6 in P0 SCs and P3 SCs were 0.269 ± 0.011 and 0.501 ± 0.014, and the grey value of Krox20 were 0.428 ± 0.025and 0.644 ± 0.012. And the similar pattern was observed in the mRNA content of these two transcription factors ( Fig 4M ).

    The expression of myelin-associated protein MBP and MPZ

    Transcription factor Oct6 interacts with transcription factor Krox20 to regulate myelination and affects the expression of myelin-specific proteins MBP and MPZ in mSC [ 5 , 38 41 ]. Therefore, we further examined the expression of MBP and MPZ in in vitro cultured SCs. At the early stage of cultured SCs, the positive expression rates of MBP and MPZ were 86.74% ± 2.66% and 91.95% ± 2.25%, respectively, and both of them reached 100% in P3 SCs ( Fig 5I ). In addition, we observed that MBP-positive SCs or MPZ-positive SCs were generally highly translucent, and those cells are transparent when observed under the light microscope ( Fig 5a 5d arrow). However, SCs with negative or low expression of MBP or MPZ had poor transparency, dark cell bodies and visible nuclei. Halos appear at the outer edge of the membranes of these cells ( Fig 5a 5d arrowhead), which differs from the typical morphology of fibroblasts (Fig (Fig5a 5a and and5b 5b asterisk).

    Fig 5
    The expression of MBP and MPZ in cultured SCs.

    The expression of NCAM and GAP43

    Besides mSC, iSC can differentiate into nmSC as well. The in vivo markers of iSC and nmSC are NCAM and GAP43, which are very similar [ 6 , 19 , 42 ]. Through our immunofluorescence experiment, we found that most of the early culture SCs expressed NCAM at the positive rate of 94.75% ± 1.19% ( Fig 6I ). Interestingly, although GAP43 is expressed in iSC and nmSC in vivo , its in vitro expression pattern was similar to Oct6’s expression, which was not fully expressed in all in vitro SCs. GAP43 showed the positive rate of 66.60% ± 7.30% and 94.06% ± 2.62% at early and later culture time points, respectively ( Fig 6I ).

    Fig 6
    The expression of NCAM and GAP43 in cultured SCs.

    Potential multiple SC stages in newborn mice

    By immunofluorescence, we detected nine SC markers, except for Sox2, expressed in SN in newborn mice. For technical reasons, we could not examine the expression rate of these SC markers in vivo in the present study. However, previous studies have demonstrated that transcription factor Sox2 is only transiently expressed in SCPs and iSCs of mouse embryos before myelination, and its expression level rapidly decreases after birth [ 5 , 28 , 29 ]. That may be the reason that Sox2 was not detected in SN harvested from either newborn mice or adult mice. Another report showed that the expression of transcription factor Oct6 peaks on day 0 after birth, followed by gradual decreasing, and no expression in mature mSCs [ 37 , 43 ]. Consistent with these previous reports, we detected expression of Oct6 in the newborn mice, but not in the adult mice. Based on our finding and previous reports, we speculated that in newborn mice SC might exist as iSC, pro-mSC, mSC and nmSC; while in adult mice SCs exist as the two major mature stages, which are nmSC and mSC.

    S100 is not a reliable pan-SC marker

    S100 is the most commonly used SC marker, and prior studies suggest that S100 is expressed in iSC, pro-mSC, mSC and nmSC in vivo , but not in SCP [ 37 , 44 46 ]. Therefore, we first examined the expression of S100 in in vitro cultured SC. We found that, in early culture, only about 85% of the SCs expressed S100, while all SCs cultured for eight days expressed S100. Some studies show that S100 is closely related to the maturation of SC [ 45 , 47 ], and therefore we interpreted our data as reflecting that in SN of newborn mice, a considerable portion of SCs are in SCP stage, which do not express S100. Then, after a period of time in vitro , the environment and various cytokines secreted by SCs, such as BDNF and GDNF, may promote SCP to differentiate into iSC [ 48 , 49 ].

    Real-time quantitative RT-PCR results showed that, in the late stage of in vitro cultured SCs, the mRNA level of S100 was unexpectedly lower than that in the earlier cultures with unknown reason. We hypothesized that these SCs may be in an immature stage, and S100 expression in these cells was negatively regulated, which led to a low mRNA level.

    Because S100 is not fully expressed in the early cultured SCs, and because a variety of other cells, such as chondrocytes, adipocytes, cardiomyocytes, skeletal muscle cells, and melanoma cells, also express S100 in vivo [ 45 , 50 , 51 ], we believe that S100 alone cannot be used as a marker to identify cultured SCs. Moreover, S100 expression in induced SCP is negative, but S100 expression can be positive if the induced cells contain other S100-positive cells. Thus, S100 cannot be used singly to identify SC-like cells derived from various types of stem cells either.

    Sox10 expression is necessary for SC identification

    Transcription factor Sox10 is a specific marker for neural crest-derived cells, and it is expressed in neural crest cells and various types of differentiated cells, including all types of SCs. Sox10, a key transcription factor, is essential for the development of SCs [ 52 ], and is involved in the regulation of myelination [ 19 ]. In this study, in vitro cultured SCs always express Sox10, which is similar to the in vivo expression pattern. Possibly the expression of Sox10 is not easily affected by environmental changes. These results suggest that Sox10 may be used to identify in vitro cultured SCs. However, Sox10 alone cannot distinguish SCs in different types or different developmental stages, and it cannot distinguish between other cell types derived from neural crest cells, which suggests that it cannot be used singly to identify SC-like cells after stem-cell induction. Since Sox10 is stably expressed in vitro and in vivo , it could serve as a necessary, but not sufficient, marker for identifying SC and SC-like cells.

    The phenotype of in vitro cultured SC is similar to that of iSC

    Transcription factor Sox2, which is in the same family as Sox10, is expressed in undifferentiated multipotent cells in various tissues, including neural stem cells [ 53 ]. After these progenitor cells differentiate, the Sox2 level decreases, indicating that Sox2 plays a very important role in maintaining cells in an undifferentiated state [ 54 , 55 ]. In addition, Sox2 is a marker of stem-cell pluripotency in a variety of tissues [ 28 , 56 , 57 ]. A previous study has found that Sox2 is first expressed in undifferentiated SC in uninjured SN, and that its level significantly increases in dedifferentiated SCs during the process of Wallerian degeneration after nerve crush [ 5 ].

    In this study, Sox2 is not significantly expressed in SCs in neonatal mouse SN, but it is expressed in most cultured SCs. This suggests that in vivo SCs are mainly in the mature state (mSC or nmSC) in newborn mice, while the majority of in vitro SCsmay be in iSC state. A possible explanation might be that in vitro SCs lose contact with axons, leading to rapid dedifferentiation from mature state into iSC, a process similar to the in vivo Wallerian degeneration process.

    Our data also showed that the majority of in vitro cultured SCs express GAP43, P75 NTR and NCAM. Since these markers are usually expressed in nmSC in normal nerves or in iSC in injured nerves [ 58 ], it is hard to tell whether in vitro cultured SCs were derived from nmSCs or iSCs. However, previous studies have found a clear distinction between nmSCs and iSCs: MPZ mRNA expression is not found in mature nmSCs [ 59 ]. Thus, the mRNA level of MPZ can be used to distinguish between these two states of SCs. Using real-time quantitative RT-PCR assay, we found that the mRNA level of MPZ in the early cultured SCs was much higher than that in the late-culture ones, suggesting that in vitro cultured SCs, especially after a long culture, were much closer to iSCs than to nmSCs.

    Of note, previous studies show that in vivo iSCs do not express Krox20 and MBP. However, our data show that with increased incubation time the ratio of Krox2-positive and MBP-positive SCs gradually reached 100%, suggesting that in vitro cultured SCs are similar, but not identical, to in vivo iSC.

    The difference of SC marker expression between in vivo and in vitro was summarized in Table 2 .

    Table 2
    Comparison of markers expression between in vivo and in vitro Schwann cells.

    Conclusions

    In conclusion, our data drew an elementary marker map of SCs cultured in vitro and showed that multiple SC stages may exist in vivo in neonatal mice. For SC identification, S100 is not a very reliable marker, while Sox10 is a necessary but not sufficient marker. In vitro cultured SCs express Sox2, P75 NTR , NCAM, GAP43, Oct6 and MPZ, and their state is similar to in vivo undifferentiated iSC and dedifferentiated iSC in damaged nerves.

    Funding Statement

    Grant sponsor: National Natural Science Foundation of China ( http://www.nsfc.gov.cn/publish/portal1/ ), grant numbers 81000522 and 31170932. The authors declare no competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

    Data Availability

    All relevant data are within the paper.

    Article information

    PLoS One. 2015; 10(4): e0123278.
    Published online 2015 Apr 10. doi: 10.1371/journal.pone.0123278
    PMCID: PMC4393255

    Zhangyin Liu

    Department of Plastic and Reconstructive Surgery, Shanghai 1 st People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China, Trauma Center, Shanghai 1 st People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China,

    Find articles by Zhangyin Liu

    Yu-Qing Jin

    Department of Plastic and Reconstructive Surgery, Shanghai 1 st People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China, Trauma Center, Shanghai 1 st People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China,

    Find articles by Yu-Qing Jin

    Lulu Chen

    Department of Plastic and Reconstructive Surgery, Shanghai 1 st People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China, Trauma Center, Shanghai 1 st People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China,

    Find articles by Lulu Chen

    Yang Wang

    Department of Plastic and Reconstructive Surgery, Shanghai 1 st People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China, Trauma Center, Shanghai 1 st People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China,

    Find articles by Yang Wang

    Xiaonan Yang

    Plastic Surgery Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of China,

    Find articles by Xiaonan Yang

    Jia Cheng

    Department of Plastic and Reconstructive Surgery, Shanghai 9 th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China,

    Find articles by Jia Cheng

    Wei Wu

    Department of Plastic and Reconstructive Surgery, Shanghai 9 th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China,

    Find articles by Wei Wu

    Zuoliang Qi

    Plastic Surgery Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of China,

    Find articles by Zuoliang Qi

    Zunli Shen

    Department of Plastic and Reconstructive Surgery, Shanghai 1 st People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China, Trauma Center, Shanghai 1 st People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China,

    Find articles by Zunli Shen
    Maria Cristina Vinci, Academic Editor
    Department of Plastic and Reconstructive Surgery, Shanghai 1 st People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China, Trauma Center, Shanghai 1 st People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China, Plastic Surgery Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of China, Department of Plastic and Reconstructive Surgery, Shanghai 9 th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China, Centro Cardiologico Monzino, ITALY, Bhatheja K, Field J. Schwann cells: origins and role in axonal maintenance and regeneration . Int J Biochem Cell Biol . 2006; 38 : 1995–1999. [ PubMed ] [ Google Scholar ]
    2. Gould VE, Moll R, Moll I, Lee I, Schwechheimer K, Franke WW. The intermediate filament complement of the spectrum of nerve sheath neoplasms . Lab Invest . 1986; 55 : 463–474. [ PubMed ] [ Google Scholar ]
    3. García Suárez O, Montaño JA, Esteban I, González Martínez T, Alvarez Abad C, López Arranz E, et al. Myelin basic protein-positive nerve fibres in human Meissner corpuscles . J Anat . 2009; 214 : 888–893. 10.1111/j.1469-7580.2009.01078.x [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
    4. Turner BJ, Ackerley S, Davies KE, Talbot K. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice . Hum Mol Genet . 2010; 19 : 815–824. 10.1093/hmg/ddp550 [ PubMed ] [ CrossRef ] [ Google Scholar ]
    5. Le N, Nagarajan R, Wang JY, Araki T, Schmidt RE, Milbrandt J. Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination . Proc Natl Acad Sci U S A . 2005; 102 : 2596–2601. [ PMC free article ] [ PubMed ] [ Google Scholar ]
    6. Yu WM, Yu H, Chen ZL, Strickland S. Disruption of laminin in the peripheral nervous system impedes nonmyelinating Schwann cell development and impairs nociceptive sensory function . Glia . 2009; 57 : 850–859. 10.1002/glia.20811 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
    7. Jung J, Cai W, Jang SY, Shin YK, Suh DJ, Kim JK, et al. Transient lysosomal activation is essential for p75 nerve growth factor receptor expression in myelinated Schwann cells during Wallerian degeneration . Anat Cell Biol . 2011; 44 : 41–49. 10.5115/acb.2011.44.1.41 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
    8. Nobbio L, Sturla L, Fiorese F, Usai C, Basile G, Moreschi I, et al. P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy . J Biol Chem . 2009; 284 : 23146–23158. 10.1074/jbc.M109.027128 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
    9. Saito H, Dahlin LB. Expression of ATF3 and axonal outgrowth are impaired after delayed nerve repair . BMC Neurosci . 2008; 9 : 88 10.1186/1471-2202-9-88 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
    10. Wakatsuki S, Yumoto N, Komatsu K, Araki T, Sehara Fujisawa A. Roles of meltrin-beta/ADAM19 in progression of Schwann cell differentiation and myelination during sciatic nerve regeneration . J Biol Chem . 2009; 284 : 2957–2966. 10.1074/jbc.M803191200 [ PubMed ] [ CrossRef ] [ Google Scholar ]
    11. Verrier JD, Lau P, Hudson L, Murashov AK, Renne R, Notterpek L. Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a . Glia . 2009; 57 : 1265–1279. 10.1002/glia.20846 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
    12. Jagalur NB, Ghazvini M, Mandemakers W, Driegen S, Maas A, Jones EA, et al. Functional dissection of the Oct6 Schwann cell enhancer reveals an essential role for dimeric Sox10 binding . J Neurosci . 2011; 31 : 8585–8594. 10.1523/JNEUROSCI.0659-11.2011 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
    13. Ryu EJ, Wang JY, Le N, Baloh RH, Gustin JA, Schmidt RE, et al. Misexpression of Pou3f1 results in peripheral nerve hypomyelination and axonal loss . J Neurosci . 2007; 27 : 11552–11559. [ PMC free article ] [ PubMed ] [ Google Scholar ]
    14. Chi GF, Kim MR, Kim DW, Jiang MH, Son Y. Schwann cells differentiated from spheroid-forming cells of rat subcutaneous fat tissue myelinate axons in the spinal cord injury . Experimental neurology . 2010; 222 : 304–317. 10.1016/j.expneurol.2010.01.008 [ PubMed ] [ CrossRef ] [ Google Scholar ]
    15. Finzsch M, Schreiner S, Kichko T, Reeh P, Tamm ER, Bösl MR, et al. Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage . J Cell Biol . 2010; 189 : 701–712. 10.1083/jcb.200912142 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
    16. Dezawa M, Takahashi I, Esaki M, Takano M, Sawada H. Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells . Eur J Neurosci . 2001; 14 : 1771–1776. [ PubMed ] [ Google Scholar ]
    17. Wang Y, Zhao Z, Ren Z, Zhao B, Zhang L, Chen J, et al. Recellularized nerve allografts with differentiated mesenchymal stem cells promote peripheral nerve regeneration . Neurosci Lett . 2012; 514 : 96–101. 10.1016/j.neulet.2012.02.066 [ PubMed ] [ CrossRef ] [ Google Scholar ]
    18. Xu Y, Liu Z, Liu L, Zhao C, Xiong F, Zhou C, et al. Neurospheres from rat adipose-derived stem cells could be induced into functional Schwann cell-like cells in vitro . BMC Neurosci . 2008; 9 : 21 10.1186/1471-2202-9-21 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
    19. Jessen KR, Mirsky R. The origin and development of glial cells in peripheral nerves . Nat Rev Neurosci . 2005; 6 : 671–682. [ PubMed ] [ Google Scholar ]
    20. Heinen A, Lehmann HC, Kury P. Negative regulators of schwann cell differentiation-novel targets for peripheral nerve therapies? J Clin Immunol . 2013; 33 Suppl 1 : S18–26. 10.1007/s10875-012-9786-9 [ PubMed ] [ CrossRef ] [ Google Scholar ]
    21. Shin YH, Lee SJ, Jung J. Extracellular ATP inhibits Schwann cell dedifferentiation and proliferation in an ex vivo model of Wallerian degeneration . Biochem Biophys Res Commun . 2013; 430 : 852–857. 10.1016/j.bbrc.2012.11.057 [ PubMed ] [ CrossRef ] [ Google Scholar ]
    22. Yang DP, Kim J, Syed N, Tung YJ, Bhaskaran A, Mindos T, et al. p38 MAPK activation promotes denervated Schwann cell phenotype and functions as a negative regulator of Schwann cell differentiation and myelination . J Neurosci . 2012; 32 : 7158–7168. 10.1523/JNEUROSCI.5812-11.2012 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
    23. Kuhlbrodt K, Herbarth B, Sock E, Hermans Borgmeyer I, Wegner M. Sox10, a novel transcriptional modulator in glial cells . J Neurosci . 1998; 18 : 237–250. [ PMC free article ] [ PubMed ] [ Google Scholar ]
    24. Jessen KR, Brennan A, Morgan L, Mirsky R, Kent A, Hashimoto Y, et al. The Schwann cell precursor and its fate: a study of cell death and differentiation during gliogenesis in rat embryonic nerves . Neuron . 1994; 12 : 509–527. [ PubMed ] [ Google Scholar ]
    25. Friedrich RP, Schlierf B, Tamm ER, Bosl MR, Wegner M. The class III POU domain protein Brn-1 can fully replace the related Oct-6 during schwann cell development and myelination . Mol Cell Biol . 2005; 25 : 1821–1829. [ PMC free article ] [ PubMed ] [ Google Scholar ]
    26. Liu H, Kim Y, Chattopadhyay S, Shubayev I, Dolkas J, Shubayev VI. Matrix metalloproteinase inhibition enhances the rate of nerve regeneration in vivo by promoting dedifferentiation and mitosis of supporting schwann cells . J Neuropathol Exp Neurol . 2010; 69 : 386–395. 10.1097/NEN.0b013e3181d68d12 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
    27. Sommer L, Suter U. The glycoprotein P0 in peripheral gliogenesis . Cell Tissue Res . 1998; 292 : 11–16. [ PubMed ] [ Google Scholar ]
    28. Adameyko I, Lallemend F, Furlan A, Zinin N, Aranda S, Kitambi SS, et al. Sox2 and Mitf cross-regulatory interactions consolidate progenitor and melanocyte lineages in the cranial neural crest . Development . 2012; 139 : 397–410. 10.1242/dev.065581 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
    29. Wakamatsu Y, Endo Y, Osumi N, Weston JA. Multiple roles of Sox2, an HMG-box transcription factor in avian neural crest development . Dev Dyn . 2004; 229 : 74–86. [ PubMed ] [ Google Scholar ]
    30. Casella GT, Bunge RP, Wood PM. Improved method for harvesting human Schwann cells from mature peripheral nerve and expansion in vitro . Glia . 1996; 17 : 327–338. [ PubMed ] [ Google Scholar ]
    31. Jin YQ, Liu W, Hong TH, Cao Y. Efficient Schwann cell purification by differential cell detachment using multiplex collagenase treatment . J Neurosci Methods . 2008; 170 : 140–148. 10.1016/j.jneumeth.2008.01.003 [ PubMed ] [ CrossRef ] [ Google Scholar ]
    32. Fields KL, Raine CS. Ultrastructure and immunocytochemistry of rat Schwann cells and fibroblasts in vitro . J Neuroimmunol . 1982; 2 : 155–166. [ PubMed ] [ Google Scholar ]
    33. Pannunzio ME, Jou IM, Long A, Wind TC, Beck G, Balian G. A new method of selecting Schwann cells from adult mouse sciatic nerve . J Neurosci Methods . 2005; 149 : 74–81. [ PubMed ] [ Google Scholar ]
    34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method . Methods . 2001; 25 : 402–408. [ PubMed ] [ Google Scholar ]
    35. Wu W, Jin YQ, Kretlow JD, Xu L, Duan HC, Qi ZL. Purification of Schwann cells from adult rats by differential detachment . Biotechnol Lett . 2009; 31 : 1703–1708. 10.1007/s10529-009-0064-8 [ PubMed ] [ CrossRef ] [ Google Scholar ]
    36. Jessen KR, Mirsky R. Negative regulation of myelination: relevance for development, injury, and demyelinating disease . Glia . 2008; 56 : 1552–1565. 10.1002/glia.20761 [ PubMed ] [ CrossRef ] [ Google Scholar ]
    37. Zorick TS, Lemke G. Schwann cell differentiation . Curr Opin Cell Biol . 1996; 8 : 870–876. [ PubMed ] [ Google Scholar ]
    38. Fröb F, Bremer M, Finzsch M, Kichko T, Reeh P, Tamm E, et al. Establishment of myelinating Schwann cells and barrier integrity between central and peripheral nervous systems depend on Sox10 . Glia . 2012; 60 : 806–819. 10.1002/glia.22310 [ PubMed ] [ CrossRef ] [ Google Scholar ]
    39. Ghislain J, Desmarquet Trin Dinh C, Jaegle M, Meijer D, Charnay P, Frain M. Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development . Development . 2002; 129 : 155–166. [ PubMed ] [ Google Scholar ]
    40. Topilko P, Schneider Maunoury S, Levi G, Baron Van Evercooren A, Chennoufi AB, Seitanidou T, et al. Krox-20 controls myelination in the peripheral nervous system . Nature . 1994; 371 : 796–799. [ PubMed ] [ Google Scholar ]
    41. Monuki ES, Kuhn R, Lemke G. Repression of the myelin P0 gene by the POU transcription factor SCIP . Mech Dev . 1993; 42 : 15–32. [ PubMed ] [ Google Scholar ]
    42. Hardy RJ, Loushin CL, Friedrich VL Jr, Chen Q, Ebersole TA, Lazzarini RA, et al. Neural cell type-specific expression of QKI proteins is altered in quakingviable mutant mice . J Neurosci . 1996; 16 : 7941–7949. [ PMC free article ] [ PubMed ] [ Google Scholar ]
    43. Blanchard AD, Sinanan A, Parmantier E, Zwart R, Broos L, Meijer D, et al. Oct-6 (SCIP/Tst-1) is expressed in Schwann cell precursors, embryonic Schwann cells, and postnatal myelinating Schwann cells: comparison with Oct-1, Krox-20, and Pax-3 . J Neurosci Res . 1996; 46 : 630–640. [ PubMed ] [ Google Scholar ]
    44. Wei Y, Zhou J, Zheng Z, Wang A, Ao Q, Gong Y, et al. An improved method for isolating Schwann cells from postnatal rat sciatic nerves . Cell Tissue Res . 2009; 337 : 361–369. 10.1007/s00441-009-0836-4 [ PubMed ] [ CrossRef ] [ Google Scholar ]
    45. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression . Brain Res Bull . 1995; 37 : 417–429. [ PubMed ] [ Google Scholar ]
    46. Zimmer DB, Song W and Zimmer WE. Isolation of a rat S100 alpha cDNA and distribution of its mRNA in rat tissues . Brain Res Bull ; 1991; 27 : 157–162. [ PubMed ] [ Google Scholar ]
    47. Shearman JD and Franks AJ. S-100 protein in Schwann cells of the developing human peripheral nerve. An immunohistochemical study . Cell Tissue Res . 1987; 249 : 459–463. [ PubMed ] [ Google Scholar ]
    48. Chan JR, Cosgaya JM, Wu YJ and Shooter EM. Neurotrophins are key mediators of the myelination program in the peripheral nervous system . Proc Natl Acad Sci U S A . 2001; 98 : 14661–14668. [ PMC free article ] [ PubMed ] [ Google Scholar ]
    49. Höke A, Ho T, Crawford TO, LeBel C, Hilt D, Griffin JW. Glial cell line-derived neurotrophic factor alters axon schwann cell units and promotes myelination in unmyelinated nerve fibers . J Neurosci . 2003; 23 : 561–567. [ PMC free article ] [ PubMed ] [ Google Scholar ]
    50. Haimoto H, Hosoda S, Kato K. Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues . Lab Invest . 1987; 57 : 489–498. [ PubMed ] [ Google Scholar ]
    51. Zimmer DB, Van Eldik LJ. Tissue distribution of rat S100 alpha and S100 beta and S100-binding proteins . Am J Physiol . 1987; 252 : C285–289. [ PubMed ] [ Google Scholar ]
    52. Britsch S, Goerich DE, Riethmacher D, Peirano RI, Rossner M, Nave KA, et al. The transcription factor Sox10 is a key regulator of peripheral glial development . Genes Dev . 2001; 15 : 66–78. [ PMC free article ] [ PubMed ] [ Google Scholar ]
    53. Bylund M, Andersson E, Novitch BG, Muhr J. Vertebrate neurogenesis is counteracted by Sox1-3 activity . Nat Neurosci . 2003; 6 : 1162–1168. [ PubMed ] [ Google Scholar ]
    54. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function . Genes Dev . 2003; 17 : 126–140. [ PMC free article ] [ PubMed ] [ Google Scholar ]
    55. Graham V, Khudyakov J, Ellis P, Pevny L. SOX2 functions to maintain neural progenitor identity . Neuron . 2003; 39 : 749–765. [ PubMed ] [ Google Scholar ]
    56. Kruger GM, Mosher JT, Bixby S, Joseph N, Iwashita T, Morrison SJ. Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness . Neuron . 2002; 35 : 657–669. [ PMC free article ] [ PubMed ] [ Google Scholar ]
    57. Parrinello S, Napoli I, Ribeiro S, Wingfield Digby P, Fedorova M, Parkinson DB, et al. EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting . Cell . 2010; 143 : 145–155. 10.1016/j.cell.2010.08.039 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
    58. Kirsch M, Campos Friz M, Vougioukas VI, Hofmann HD. Wallerian degeneration and axonal regeneration after sciatic nerve crush are altered in ICAM-1-deficient mice . Cell Tissue Res . 2009; 338 : 19–28. 10.1007/s00441-009-0837-3 [ PubMed ] [ CrossRef ] [ Google Scholar ]
    59. Lee M, Brennan A, Blanchard A, Zoidl G, Dong Z, Tabernero A, et al. P0 is constitutively expressed in the rat neural crest and embryonic nerves and is negatively and positively regulated by axons to generate non-myelin-forming and myelin-forming Schwann cells, respectively . Mol Cell Neurosci . 1997; 8 : 336–350. NCAMGAP43MBPMPZAdult SN(+)(+)(-)(+)(+)(+)(+)(+)(+)(+)Newborn SN(+)(+)(+)(+)(+)(+)(+)(+)(+)(+)P0 SCs85.84% ± 1.86%100%82.60% ± 4.13%91.67% ± 4.13%100%93.57% ± 3.40%94.75% ± 1.19%66.60% ± 7.30%86.74% ± 2.66%91.95% ± 2.25%P3 SCs100%100%92.64% ± 3.49%100%100%100%100%94.06% ± 2.62%100%100%